Toll Free: 1-888-928-9744
Published: Feb, 2014 | Pages:
39 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Raptor Pharmaceuticals Corp. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Raptor Pharmaceuticals Corp. - Product Pipeline Review - 2014', provides an overview of the Raptor Pharmaceuticals Corp.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Raptor Pharmaceuticals Corp.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Raptor Pharmaceuticals Corp. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Raptor Pharmaceuticals Corp.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Raptor Pharmaceuticals Corp.'s pipeline products Reasons to buy - Evaluate Raptor Pharmaceuticals Corp.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Raptor Pharmaceuticals Corp. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Raptor Pharmaceuticals Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Raptor Pharmaceuticals Corp. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Raptor Pharmaceuticals Corp. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Raptor Pharmaceuticals Corp. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Raptor Pharmaceuticals Corp. Snapshot 5 Raptor Pharmaceuticals Corp. Overview 5 Key Information 5 Key Facts 5 Raptor Pharmaceuticals Corp. - Research and Development Overview 6 Key Therapeutic Areas 6 Raptor Pharmaceuticals Corp. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Raptor Pharmaceuticals Corp. - Pipeline Products Glance 11 Raptor Pharmaceuticals Corp. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Raptor Pharmaceuticals Corp. - Early Stage Pipeline Products 12 IND/CTA Filed Products/Combination Treatment Modalities 12 Preclinical Products/Combination Treatment Modalities 13 Raptor Pharmaceuticals Corp. - Unknown Stage Pipeline Products 14 Unknown Products/Combination Treatment Modalities 14 Raptor Pharmaceuticals Corp. - Drug Profiles 15 cysteamine DR 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 fomepizole 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Cysteamine Dioxygenase Inhibitor 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 HepTide 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 NGX-426 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 tezampanel 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Raptor Pharmaceuticals Corp. - Pipeline Analysis 25 Raptor Pharmaceuticals Corp. - Pipeline Products by Target 25 Raptor Pharmaceuticals Corp. - Pipeline Products by Route of Administration 26 Raptor Pharmaceuticals Corp. - Pipeline Products by Molecule Type 27 Raptor Pharmaceuticals Corp. - Pipeline Products by Mechanism of Action 28 Raptor Pharmaceuticals Corp. - Recent Pipeline Updates 29 Raptor Pharmaceuticals Corp. - Dormant Projects 35 Raptor Pharmaceuticals Corp. - Discontinued Pipeline Products 36 Discontinued Pipeline Product Profiles 36 NGX-426 36 tezampanel 36 WntTide 36 Raptor Pharmaceuticals Corp. - Locations And Subsidiaries 37 Head Office 37 Other Locations & Subsidiaries 37 Appendix 38 Methodology 38 Coverage 38 Secondary Research 38 Primary Research 38 Expert Panel Validation 38 Contact Us 39 Disclaimer 39
List of Tables Raptor Pharmaceuticals Corp., Key Information 5 Raptor Pharmaceuticals Corp., Key Facts 5 Raptor Pharmaceuticals Corp. - Pipeline by Indication, 2014 8 Raptor Pharmaceuticals Corp. - Pipeline by Stage of Development, 2014 9 Raptor Pharmaceuticals Corp. - Monotherapy Products in Pipeline, 2014 10 Raptor Pharmaceuticals Corp. - Phase II, 2014 11 Raptor Pharmaceuticals Corp. - IND/CTA Filed, 2014 12 Raptor Pharmaceuticals Corp. - Preclinical, 2014 13 Raptor Pharmaceuticals Corp. - Unknown, 2014 14 Raptor Pharmaceuticals Corp. - Pipeline by Target, 2014 25 Raptor Pharmaceuticals Corp. - Pipeline by Route of Administration, 2014 26 Raptor Pharmaceuticals Corp. - Pipeline by Molecule Type, 2014 27 Raptor Pharmaceuticals Corp. - Pipeline Products by Mechanism of Action, 2014 28 Raptor Pharmaceuticals Corp. - Recent Pipeline Updates, 2014 29 Raptor Pharmaceuticals Corp. - Dormant Developmental Projects,2014 35 Raptor Pharmaceuticals Corp. - Discontinued Pipeline Products, 2014 36 Raptor Pharmaceuticals Corp., Subsidiaries 37
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.